Related Experiment Video
Updated: Jan 16, 2026

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Regional Citrate Anticoagulation in Pediatric Patients: Dealing with Practice Points
Zaccaria Ricci1,2, Akash Deep3, Stuart L Goldstein4
1Department of Emergency and Critical Care, Anesthesia and Pediatric Intensive Care Unit, Meyer Children's Hospital, IRCCS, Florence, Italy, zaccaria.ricci@unifi.it.
Insights
Regional citrate anticoagulation (RCA) is safe for pediatric continuous renal replacement therapy (CRRT). Careful consideration of citrate concentration and patient factors is crucial for safe and effective RCA in children.
Area of Science:
- Pediatric Nephrology
- Critical Care Medicine
- Pharmacology
Background:
- Regional citrate anticoagulation (RCA) is a safe and effective method for continuous renal replacement therapy (CRRT) in both adult and pediatric populations.
- The same equipment and solutions are utilized for RCA in pediatric and adult CRRT.
- Understanding the nuances of RCA in pediatrics is essential due to potential impacts on CRRT parameters.
Purpose of the Study:
- To review the practice concepts of RCA in the pediatric setting.
- To highlight the importance of citrate concentration and its impact on CRRT parameters in children.
- To provide clinicians with detailed knowledge for approaching RCA in pediatric patients.
Main Methods:
- Review of available literature and commercial citrate formulations for RCA in CRRT.
- Analysis of the impact of different citrate concentrations on CRRT dose, filtration fraction, circuit pressures, and fluid flow.
- Discussion of factors to consider when prescribing RCA in children, including citrate dose, load, concentration, and patient metabolism.
Main Results:
- Three commercial citrate formulations for RCA exist: concentrated (4%), semi-concentrated (ACD-A, 75 mmol/L), and diluted (18 mmol/L).
- The volume of predilution RCA infusion impacts CRRT dose, filtration fraction, circuit pressures, and fluid flow, with greater relevance in smaller patients.
- Different citrate formulations lead to variations in CRRT settings, sodium loads, filtration fractions, and dialytic doses for a given citrate dose and blood flow rate.
Conclusions:
- The choice of citrate formulation significantly influences CRRT delivery in pediatric patients.
- Clinicians must carefully consider blood pump flow rate, citrate dose, load, concentration, and the patient's metabolic capacity.
- Contextualizing RCA prescription based on available citrate concentrations is critical for optimizing outcomes in pediatric CRRT.
Background:
Regional citrate anticoagulation (RCA) for continuous renal replacement therapy (CRRT) has been shown to be safe and effective both in adults and children. The equipment and the solutions available in the pediatric setting are the same as in adults.
Summary:
Currently three commercially available citrate formulations for RCA during continuous renal replacement therapy CRRT are present: concentrated (4% trisodium citrate, 136 mmol/L), semi-concentrated (anticoagulant dextrose-A, ACD-A, 75 mmol/L) and diluted (Prismocitrate/Regiocit, 18 mmol/L). RCA is delivered as a predilution infusion solution; therefore, its volume in dedicated commercially available citrate solutions impacts continuous renal replacement (CRRT) dose, filtration fraction, circuit pressures, and fluid flow. These aspects represent crucial details in the pediatric setting, and their relevance is more important as the smaller the patient's body weight is. Thus, when RCA is prescribed in children, the blood pump flow rate, the dose, the load and the concentration of citrate, and the patient's ability to metabolize citrate should be considered carefully and specifically contextualized by the citrate concentration available in each center. This technical review will describe these practice concepts that should be known in detail by the clinician approaching RCA in the pediatric setting.
Key Messages:
Citrate "dose" is the citrate concentration in the blood running in the CRRT circuit. Citrate "load" represents the mass of citrate that is delivered to the circuit per each treatment hour. For a given citrate dose and blood flow rate, very different CRRT settings, sodium loads, filtration fractions, and dialytic doses are delivered by choosing the different formulations.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

